Virological Outcomes After Switching to Abacavir/Lamivudine/Dolutegravir Combined with Adherence Support in People Living with HIV with Poor Adherence: A Phase IV, Multicentre Randomized Prospective Open Label Study (TriiADD-CTN 286)-Reference-Cited by-同舟云学术

Virological Outcomes After Switching to Abacavir/Lamivudine/Dolutegravir Combined with Adherence Support in People Living with HIV with Poor Adherence: A Phase IV, Multicentre Randomized Prospective Open Label Study (TriiADD-CTN 286)

Published:2022-12 Issue: Volume:Volume 16 Page:3267-3281
ISSN:1177-889X
Container-title:Patient Preference and Adherence
language:en
Short-container-title:PPA

Author:

Klein Marina B^ORCID,Young Jim^ORCID,Ortiz-Paredes David^ORCID,Wang Shouao,Walmsley Sharon,Wong Alexander,Martel-Laferrière Valérie,Pick Neora^ORCID,Conway Brian,Angel Jonathan,Baril Jean-Guy,Fraser Chris,Lebouché Bertrand,Tan Darrell HS^ORCID,Sandre Roger,Trottier Sylvie,Peiris Hansi,Jayaraman Jayamarx,Singer Joel

Publisher

Informa UK Limited

Subject

Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Social Sciences (miscellaneous),Medicine (miscellaneous)

Reference53 articles.

1. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services; 2013. Available from: https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/adult-adolescent-arv/guidelines-adult-adolescent-arv.pdf. Accessed December 1, 2022.

2. Prediction of adherence to antiretroviral therapy: A one-year longitudinal study

3. Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic

4. Stability of Adherence to Highly Active Antiretroviral Therapy Over Time Among Clients Enrolled in the Treatment Adherence Demonstration Project

5. Real-World Adherence to Antiretroviral Therapy Among HIV-1 Patients Across the United States